Hormone tracking and data collection in primary aldosteronism
Part of Hormones & metabolism clinical trials.
This study tracks hormone levels and collects different health information to better understand primary aldosteronism, a condition where your adrenal glands produce too much aldosterone. It aims to improve diagnosis and care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have suspected or confirmed primary aldosteronism (a condition where your adrenal glands produce too much of the hormone aldosterone).
- You are not pregnant.
- You do not have adrenal failure (when your adrenal glands don't work properly) and are not currently taking steroid medications (like prednisone, hydrocortisone, or inhaled steroids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at better ways to diagnose primary aldosteronism when lab results suggest the condition but standard diagnosis criteria haven’t been met. It may help you understand what your hormone pattern means and whether you need specific treatment.
This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.
This study follows people with primary aldosteronism over time to understand their health outcomes. It may help doctors learn how to better treat this condition.
This study tests whether adjusting a type of blood pressure medication (called a mineralocorticoid receptor antagonist) based on renin levels is safe and helpful for people with primary aldosteronism. It aims to find a better way to manage the condition.
This study looks at the genes and molecules in people with primary aldosteronism (a condition where the adrenal glands make too much of the hormone aldosterone), primary hypertension (high blood pressure), and healthy volunteers. The goal is to better understand these conditions and find better ways to diagnose and treat them.
This trial tests whether a new drug called SAL0140 can safely lower blood pressure in people with primary aldosteronism, a condition where the body makes too much of a hormone that raises blood pressure. You'll take the study drug at different dose levels while your blood pressure and kidney function are monitored.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.